APT Medical Inc. Overview

APT Medical Inc., a prominent Chinese biotechnology company headquartered in Shanghai, is known for its focus on developing innovative solutions targeting various diseases, particularly those related to cardiovascular health. The company is listed on the Shanghai Stock Exchange, reflecting its significant presence in the biotechnology sector.

Financial Highlights

As of May 11, 2025, APT Medical Inc. reported a close price of 399.01 CNY. Over the past year, the company’s stock has experienced fluctuations, reaching a 52-week high of 563 CNY on May 14, 2024, and a 52-week low of 303.52 CNY on July 29, 2024. The company’s market capitalization stands at 41,157,898,127 CNY, indicating its substantial valuation in the market.

The price-to-earnings (P/E) ratio for APT Medical Inc. is currently 56.3089, suggesting investor expectations regarding the company’s future earnings growth.

Company Focus

APT Medical Inc. is dedicated to advancing healthcare through its specialization in cardiovascular health solutions. The company’s commitment to innovation positions it as a key player in addressing critical health challenges within the biotechnology industry.

Conclusion

APT Medical Inc. continues to be a significant entity in the biotechnology landscape, with its strategic focus on cardiovascular health and robust financial performance. As it remains listed on the Shanghai Stock Exchange, the company is poised to maintain its influence in the sector.